InspireMD Inc (NSPR)
Healthcare
Medical Devices
0.65 $
-3.2%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns InspireMD Inc (NSPR)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 56.1% of the shares are freely tradable; institutional investors hold 48.7%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
48.7%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
19.8%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
56.1%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
0.1%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
47Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Rosalind Advisors, Inc. | 8.34 | 3,905,743 | +0.0 | 03/31/2026 |
| Nantahala Capital Management, LLC | 7.21 | 3,376,484 | +0.0 | 03/31/2026 |
| Aberdeen Group PLC | 6.78 | 3,173,364 | +0.0 | 03/31/2026 |
| Orbimed Advisors, LLC | 6.69 | 3,133,405 | +0.0 | 03/31/2026 |
| Parkman Healthcare Partners LLC | 5.16 | 2,416,518 | +0.0 | 03/31/2026 |
| Velan Capital Investment Management LP | 4.48 | 2,099,652 | -2.1 | 03/31/2026 |
| Marshall Wace Asset Management Ltd | 3.97 | 1,860,405 | +0.0 | 03/31/2026 |
| Soleus Capital Management, L.P. | 2.23 | 1,045,708 | -9.1 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| abrdn Healthcare Investors | 3.72 | 1,743,519 | +16.0 | 05/31/2026 |
| abrdn Healthcare Opportunities | 2.26 | 1,059,385 | +0.0 | 04/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.